Yahoo
NasdaqGS - Delayed Quote USD

Progyny, Inc. (PGNY)

18.60 +0.02 (+0.11%)
At close: May 1 at 4:00:00 PM EDT
18.60 0.00 (0.00%)
After hours: May 1 at 5:13:57 PM EDT
Trade Progyny on Coinbase
Chart Range Bar
Loading chart for PGNY
  • Previous Close 18.58
  • Open 18.67
  • Bid 13.60 x 100
  • Ask 23.91 x 100
  • Day's Range 18.49 - 18.98
  • 52 Week Range 16.10 - 28.75
  • Volume 1,742,666
  • Avg. Volume 1,488,104
  • Market Cap (intraday) 1.523B
  • Beta (5Y Monthly) 0.99
  • PE Ratio (TTM) 28.62
  • EPS (TTM) 0.65
  • Earnings Date May 7, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 27.45

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

www.progyny.com

835

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Performance Overview: PGNY

Trailing total returns as of 5/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PGNY
27.57%
S&P 500 (^GSPC)
5.62%

1-Year Return

PGNY
18.42%
S&P 500 (^GSPC)
29.01%

3-Year Return

PGNY
44.63%
S&P 500 (^GSPC)
73.47%

5-Year Return

PGNY
67.32%
S&P 500 (^GSPC)
72.92%

Earnings Trends: PGNY

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 318.4M
Earnings 42.89M

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

0
100M
200M
300M

Analyst Insights: PGNY

View More

Analyst Price Targets

19.00
27.45 Average
18.60 Current
31.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 3/20/2026
Analyst Barclays
Rating Action Maintains
Rating Overweight
Price Action Lowers
Price Target 29 -> 23

Statistics: PGNY

View More

Valuation Measures

Annual
As of 5/1/2026
  • Market Cap

    1.46B

  • Enterprise Value

    1.17B

  • Trailing P/E

    28.62

  • Forward P/E

    10.00

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.30

  • Price/Book (mrq)

    2.82

  • Enterprise Value/Revenue

    0.91

  • Enterprise Value/EBITDA

    13.02

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.54%

  • Return on Assets (ttm)

    8.61%

  • Return on Equity (ttm)

    12.48%

  • Revenue (ttm)

    1.29B

  • Net Income Avi to Common (ttm)

    58.52M

  • Diluted EPS (ttm)

    0.65

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    310.1M

  • Total Debt/Equity (mrq)

    5.37%

  • Levered Free Cash Flow (ttm)

    212.5M

Compare To: PGNY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: PGNY

Fair Value

18.60 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports: PGNY

View More
  • What does Argus have to say about PGNY?

    PROGYNY INC has an Investment Rating of HOLD; a target price of $17.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of High; and a Value Subrating of Medium.

    Rating
    Price Target
  • Raising target price to $17.00

    PROGYNY INC has an Investment Rating of HOLD; a target price of $17.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of High; and a Value Subrating of Medium.

    Rating
    Price Target
  • What does Argus have to say about PGNY?

    PROGYNY INC has an Investment Rating of HOLD; a target price of $16.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of High; and a Value Subrating of Low.

    Rating
    Price Target
  • What does Argus have to say about PGNY?

    PROGYNY INC has an Investment Rating of HOLD; a target price of $16.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of High; and a Value Subrating of Low.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: